Oracle Alpha Inc. Avidity Biosciences, Inc. Transaction History
Oracle Alpha Inc.
- $55.7 Billion
- Q1 2024
A detailed history of Oracle Alpha Inc. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Oracle Alpha Inc. holds 10,518 shares of RNA stock, worth $346,357. This represents 0.48% of its overall portfolio holdings.
Number of Shares
10,518
Previous 12,996
19.07%
Holding current value
$346,357
Previous $118 Million
128.22%
% of portfolio
0.48%
Previous 0.15%
Shares
2 transactions
Others Institutions Holding RNA
# of Institutions
250Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$350 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$304 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$284 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$268 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$232 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.72B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...